Mr. Jim Hutchens reports

IMAGIN MEDICAL SELECTS LIGHTHOUSE IMAGING AS I/BLUE(TM) IMAGING SYSTEM CONTRACT MANUFACTURER

Imagin Medical Inc. has selected Lighthouse Imaging as the contract manufacturer for the company's i/Blue imaging system.

Founded in 1984, Lighthouse Imaging is a Food and Drug Administration-registered and ISO 13485:2016-certified contract manufacturer that specializes in providing manufacturing services for medical devices, including full visualization systems and accessories. Lighthouse designs, develops and manufactures state-of-the-art imaging systems for minimally invasive procedures, including chip-on-tip endoscopic imaging systems; robotic surgery systems; high-definition 2-D and 3-D systems; and reusable and single use systems.

"Selecting a contract manufacturer for our i/Blue imaging system is a major step toward market approval, especially given the significant validation test data the FDA requires as part of the device approval process," said Jim Hutchens, Imagin's president and chief executive officer. "We would like to thank our contract development firm, Optel, for creating the i/Blue system's unique miniaturized design and progressing the system to this point. We are looking forward to working with Lighthouse to continue to advance i/Blue toward commercialization."

Tom Snyder, chief executive officer of Lighthouse, commented: "The Lighthouse engineering team is adept at refining medical device designs and developing manufacturing processes to meet performance, cost, quality and regulatory requirements. Our fully compliant process is proven to be efficient and effective at rapidly developing medical devices. We understand the rigour required to meet the expectations of the FDA for Class III devices and we are excited to work with Imagin to drive the i/Blue system through commercialization."

About Imagin Medical Inc.

Imagin Medical is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive procedures. The company believes its first product, the i/Blue imaging system, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting cancer for removal, helping to reduce recurrence rates. The company's initial focus is bladder cancer.

We seek Safe Harbor.